879 results on '"Patrono C"'
Search Results
102. Clinical and genetic study of two Italian families with silver sindrom
103. Clinical and genetic study of two Italian families with silver syndrome
104. Silver syndrome: clinicogenetic analysis of two Italian pedigrees
105. Association of APOE ε4 allele with vascular dementia in Italian population
106. Expert consensus document on the use of antiplatelet agents.:The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology
107. Plasma and Synovial Levels of Tolmetin and Its Inhibitory Effect on Prostaglandins in Patients with Rheumatoid Arthritis
108. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
109. The T9176G mt DNA mutation severely affects AATP production and results in Leigh syndrome
110. Altered lactate kinetics from exercising muscle in Hereditary Spastic Paraplegia
111. Silver syndrome variant of hereditary spastic paraplegia: A locus to 4p and allelism with SPG4.
112. Role of platelet activation in dementia
113. Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?
114. Cigarette Smoking Knowledge and Perceptions Among Students in Four Italian Medical Schools
115. COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
116. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis
117. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction
118. Low-Dose Aspirin, Coxibs, and other NSAIDS: A Clinical Mosaic Emerges
119. Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity
120. ENTRY RATE AND METABOLISM OF LEUKOTRIENE C4 INTO THE VASCULAR COMPARTMENT IN HEALTHY SUBJECTS
121. RELEASE OF CONTRACTING FACTORS BY AORTAE OF NORMAL AND ATHEROSCLEROSIS RABBITS
122. DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
123. NOS Evaluations in Human Dental Pulp-Capping with MTA and Calcium-Hydroxide
124. We-P11:78 Insulin resistance as a determinant of platelet activation in obese women
125. Th-P17:431 Analysis of free fatty acids in atherosclerotic plaques
126. Th-W51:4 Lipid peroxidation as a determinant of platelet activation in hypertensives with microalbuminuria
127. Tu-W26:7 Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinemia due to MTHFR C677T polymorphism
128. Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology
129. Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts
130. Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?
131. SPG3A
132. Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues
133. Antiplatelet strategies*1
134. Oxidative Stress and Platelet Activation in Homozygous Homocystinuria
135. Respiratory chain defects in hereditary spastic paraplegias
136. The T9176G mtDNA mutation severely affects ATP production and results in Leigh syndrome
137. Identification of novel WFS1 mutations in Italian children with Wolfram syndrome
138. Intrafamilial variability in hereditary spastic paraplegia associated with an SPG4 gene mutation
139. Rapid detection of the 35delG mutation in the GJB2 gene in childhood deafness
140. A novel SURF1 mutation results in Leigh syndrome with peripheral neuropathy caused by cytochrome c oxidase deficiency
141. Novel 7-DHCR mutation in a child with Smith-Lemli-Opitz syndrome
142. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
143. A novel 7-DHCR mutation in a lebanese child with Smith-Lemli-Opitz syndrome
144. Unstable coronary artery disease: need for long-term antithrombotic treatment? Aspirin alone may not be the ideal antithrombotic strategy, but that's what we have adequate trial data for
145. 117. Hirudin does not affect the abnormally high thromboxane biosynthesis in homozygous homocystinuria
146. 118. Infusion of hirudin does not correct the abnormally high thromboxane A2 biosynthesis in homozygous homocystinuria
147. Effects of flurbiprofen and its nitroxybutylester derivative on the cycloxygenase activity of human blood prostaglandin endoperoxide synthases
148. Induction of prostaglandin endoperoxide synthase 2 in monocytes of human whole blood is associated with cyclooxygenase-dependent isoprostane formation
149. The antiinflammatory compounds L-745,337 and NS-398 are selective inhibitors of prostaglandin endoperoxide synthase-2 in human blood monocytes
150. Evidence for episodic platelet activation in acute ischemic stroke.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.